181 related articles for article (PubMed ID: 35082167)
21. P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer.
Yi Y; Li P; Huang Y; Chen D; Fan S; Wang J; Yang M; Zeng S; Deng J; Lv X; Luo K; He Z; Liu H
Oncogene; 2022 Sep; 41(37):4318-4329. PubMed ID: 35986102
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study.
Sa-Ngiamwibool P; Hamasaki M; Kinoshita Y; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Kasai T; Kushitani K; Takeshima Y; Hiroshima K; Iwasaki A; Nabeshima K
Lung Cancer; 2023 Jan; 175():27-35. PubMed ID: 36442384
[TBL] [Abstract][Full Text] [Related]
24. Genomic landscape of pleural and peritoneal mesothelioma tumours.
Hiltbrunner S; Fleischmann Z; Sokol ES; Zoche M; Felley-Bosco E; Curioni-Fontecedro A
Br J Cancer; 2022 Nov; 127(11):1997-2005. PubMed ID: 36138075
[TBL] [Abstract][Full Text] [Related]
25. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation.
Li T; Zhang J; Zhu F; Wen W; Zykova T; Li X; Liu K; Peng C; Ma W; Shi G; Dong Z; Bode AM; Dong Z
Carcinogenesis; 2011 May; 32(5):659-66. PubMed ID: 21177766
[TBL] [Abstract][Full Text] [Related]
26. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
27. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
Sneddon S; Patch AM; Dick IM; Kazakoff S; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
BMC Cancer; 2017 Jun; 17(1):396. PubMed ID: 28577549
[TBL] [Abstract][Full Text] [Related]
28. p21-activated kinase 2 regulates HSPC cytoskeleton, migration, and homing via CDC42 activation and interaction with β-Pix.
Reddy PN; Radu M; Xu K; Wood J; Harris CE; Chernoff J; Williams DA
Blood; 2016 Apr; 127(16):1967-75. PubMed ID: 26932803
[TBL] [Abstract][Full Text] [Related]
29. Animal models of malignant mesothelioma.
Kane AB
Inhal Toxicol; 2006 Nov; 18(12):1001-4. PubMed ID: 16920675
[TBL] [Abstract][Full Text] [Related]
30. Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.
De la Mota-Peynado A; Chernoff J; Beeser A
J Biol Chem; 2011 Apr; 286(15):13603-11. PubMed ID: 21317288
[TBL] [Abstract][Full Text] [Related]
31. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
[TBL] [Abstract][Full Text] [Related]
32. Expansion of BCR/ABL1
Edlinger L; Berger-Becvar A; Menzl I; Hoermann G; Greiner G; Grundschober E; Bago-Horvath Z; Al-Zoughbi W; Hoefler G; Brostjan C; Gille L; Moriggl R; Spittler A; Sexl V; Hoelbl-Kovacic A
Br J Haematol; 2017 Oct; 179(2):229-241. PubMed ID: 28707321
[TBL] [Abstract][Full Text] [Related]
33. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.
Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K
Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of CRISPR/Cas9-mediated NF2
Wahiduzzaman M; Karnan S; Ota A; Hanamura I; Murakami H; Inoko A; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y
Cancer Sci; 2019 Jan; 110(1):180-193. PubMed ID: 30417500
[TBL] [Abstract][Full Text] [Related]
35. Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.
Wilkes MC; Repellin CE; Hong M; Bracamonte M; Penheiter SG; Borg JP; Leof EB
Dev Cell; 2009 Mar; 16(3):433-44. PubMed ID: 19289088
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-455-3p promotes TGF-β signaling and inhibits osteoarthritis development by directly targeting PAK2.
Hu S; Zhao X; Mao G; Zhang Z; Wen X; Zhang C; Liao W; Zhang Z
Exp Mol Med; 2019 Oct; 51(10):1-13. PubMed ID: 31586040
[TBL] [Abstract][Full Text] [Related]
37. p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.
Chow HY; Stepanova D; Koch J; Chernoff J
PLoS One; 2010 Nov; 5(11):e13791. PubMed ID: 21072183
[TBL] [Abstract][Full Text] [Related]
38. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract][Full Text] [Related]
39. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.
Nuche-Berenguer B; Jensen RT
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2371-82. PubMed ID: 25979836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]